Related Experiment Video
Updated: Jun 9, 2025

Real-Time Dynamic Navigation System for the Precise Quad-Zygomatic Implant Placement in a Patient with a Severely Atrophic Maxilla
Published on: October 18, 2021
Venous Thromboembolism Prophylaxis in Maxillofacial Surgery
Inês Camelo1, Flávia Pereira1, Mariana Cebotari1
1Maxillofacial Surgery Department, Centro Hospitalar Universitário de São João, Porto, PRT.
Abstract:
The aim of this article is to conduct a literature review concerning the need for venous thromboembolism (VTE) prophylaxis among patients undergoing maxillofacial surgery. This article addresses the diagnosis of VTE, patient risk stratification, and prophylactic measures suitable for the various groups of interest in maxillofacial surgery. From a pool of 44 articles identified, nine were chosen as the most pertinent to the aims of this review. Despite limited data on this topic, individuals undergoing oral and maxillofacial surgery generally exhibit a low risk of VTE. This review emphasizes the importance of implementing prophylactic measures tailored to individual risk factors. Pharmacological prophylaxis merits consideration, particularly when the Caprini score is ≥7. However, further research is needed to optimize prophylactic strategies in maxillofacial surgery.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Tonsillitis II: Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism III: Nursing Management
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

